Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization
Heart failure remains a huge societal concern despite medical advancement, with an annual direct cost of over $30 billion. While guideline-directed medical therapy (GDMT) is proven to reduce morbidity and mortality, many eligible patients with heart failure with reduced ejection fraction (HFrEF) are...
Main Authors: | Neal M Dixit, Shivani Shah, Boback Ziaeian, Gregg C Fonarow, Jeffrey J Hsu |
---|---|
Format: | Article |
Language: | English |
Published: |
Radcliffe Medical Media
2021-04-01
|
Series: | US Cardiology Review |
Online Access: | https://www.uscjournal.com/articleindex/usc.2020.29 |
Similar Items
-
Evaluation of a guideline directed medical therapy titration program in patients with heart failure with reduced ejection fraction
by: Kathir Balakumaran, et al.
Published: (2019-03-01) -
Patient compliance and physicians’ adherence to guidelines on heart failure with reduced ejection fraction
by: V. N. Larina, et al.
Published: (2020-04-01) -
Adherence to guideline-directed medical and device Therapy in outpAtients with heart failure with reduced ejection fraction: The ATA study
by: Umut Kocabaş, et al.
Published: (2020-07-01) -
Prognostic Relevance of Anxiety in Distinct Phenotypes of Heart Failure:Heart Failurewith Reduced Ejection Fraction and Heart Failure with Preserved Ejection Fraction
by: HSU, BO-CHENG, et al.
Published: (2019) -
Management of Heart Failure with Reduced Ejection Fraction after ESC 2016 Heart Failure Guidelines: The Linx Registry
by: Fernando deFrutos, et al.
Published: (2020-02-01)